Evidence map›Paper›PMID 39813081›Full record

ArticleJMIR formative research2025

Cardiomeds, an mHealth App for Self-Management to Support Swiss Patients With Heart Failure: 2-Stage Mixed Methods Usability Study.

Lisa Simioni, Elena Tessitore, Hamdi Hagberg, Aurélie Schneider-Paccot, Katherine Blondon, Liliane Gschwind, Philippe Meyer, Frederic Ehrler

Abstract read
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisa SimioniFaculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0009-0000-7411-827X
Elena TessitoreFaculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0000-0003-1680-0152
Hamdi HagbergDepartment of Computer Science, University Hospital of Geneva, Geneva, Switzerland.ORCID 0009-0005-6117-4922
Aurélie Schneider-PaccotDepartment of Cardiology, University Hospital of Geneva, Geneva, Switzerland.ORCID 0009-0003-5872-882X
Katherine BlondonFaculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-9407-8516
Liliane GschwindDepartment of Pharmacy, University Hospital of Geneva, Geneva, Switzerland.ORCID 0009-0001-6896-3327
Philippe MeyerDepartment of Cardiology, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0002-2430-8953
Frederic EhrlerDepartment of Computer Science, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0001-9734-3242

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMobile health apps have shown promising results in improving self-management of several chronic diseases in patients. We have developed a mobile health app (Cardiomeds) dedicated to patients with heart failure (HF). This app includes an interactive medication list; daily self-monitoring of symptoms, weight, blood pressure, and heart rate; and educational information on HF delivered through various formats.

objectiveThis study aimed to perform a mixed methods usability study of Cardiomeds.

methodsSmartphone users with HF were recruited from the HF outpatient clinic at the University Hospital of Geneva. The usability test was conducted in 2 stages, with modifications made to the app after the first stage to address major usability issues. Each stage required 10 participants to perform 14 tasks, such as entering vital signs, entering a new medication and time of intake, or finding information about HF. Each task was timed, sessions were recorded, and all data were anonymized. After completing the tasks, patients completed the System Usability Scale 10-item questionnaire and answered 5 open questions about their perceptions of Cardiomeds.

resultsTwenty patients with HF, 75% (15/20) of whom were men, with a mean age of 55 years, were included in this study. The average time to complete all 14 tasks was 18 (SD 5.7) minutes. Manual medication entry was the most time-consuming task, taking an average of 154.40 (SD 68.08) seconds in the first stage, 103.10 (SD 42.76) seconds in the second stage, and 128 (SD 63) seconds overall. The mean overall success rate was 77% (SD 0.23%) for the first stage and 94% (SD 0.07%) for the second stage. A total of 30% (3/10) of participants in the first stage completed all tasks without any help compared with 50% (5/10) of participants during the second stage. The average System Usability Scale score was 80% (SD 17%), showing a slight increase from 79% (SD 16%) in the first stage to 80% (SD 28%) in the second stage, which qualifies the app as "good" in terms of usability. Between the 2 stages, part of the app interface was redesigned to address the key issues identified in the first stage. Despite these improvements, problems related to guidance were frequent and comprised 36% (8/22) of the problems in the first stage and 40% (6/15) in the second stage. In response to open questions, 85% (17/20) of the participants responded that they would like to use the app when it became available.

conclusionsThe usability test indicated that Cardiomeds is a suitable and user-friendly app for patients with HF. The app will be further tested in a randomized clinical trial (2022-00731) after acute HF hospitalization to assess its impact on patients' knowledge about HF, self-care, and quality of life.

Indexed as

Heart FailureMobile ApplicationsSelf-ManagementAdultAgedFemaleHumansMaleMiddle AgedSurveys and QuestionnairesSwitzerlandTelemedicineCardiomedschronic diseaseeHealthheart failureHFinteractivemedicationmHealthmobile appmobile healthmobile phonepatient empowermentself-monitoringsmartphoneusabilityusability test

Identifiers

PMID39813081
PMCPMC11780291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.